Novus Continues Its Growth, As Cannabis Sector Outperforms the S&P 500 Despite Light Trading Volume

About this update from Novus Acquisition & Development Corp.

Novus Acquisition and Development, Corp. (OTC Markets: ( NDEV ), through its wholly-owned subsidiary WCIG Insurance Services, Inc. Operates as a national supplemental health insurance carrier and, the nation’s first health carrier offering cannabis that is included in health plans for recreational and medicinal users. Addresses about Cannabis Index’s light trading volumes. As healthcare costs rise faster than inflation, Novus’ business model continues to increase its revenue metrics, even during the lower-than-expected trading volume that the entire Cannabis Sector is experiencing. According to this video by Cannabis Investing Newsletter Forum, rapid growth rates for cannabis stocks have doubled and outpaced that of the broader stock market. Therefore, a long-term approach should be considered, when federal legalization occurs, bringing in more investors to support cannabis stocks with a conceivable pricing upswing. For Novus, by way of comparison, the S&P 500 over the past 2.5 years, quarter-over-quarter of 3Q 2022 was 13.3 %, and Novus' Gross Revenue increased by 12.27% during the same period. Since our inception in late 2015, we are continually strengthening our infrastructure, with: 300+ Cannabis Verticals in our Provider Network, 1,200 Selling Affiliate Insurance Agents, 12 participating major and regional health carriers, with executed agreements that embed our plans with their offerings Further research will demonstrate the following: Novus Financial Highlights: Novus’ 3Q of 2022, the points below show the financial condition of the Company’s business model.  No Dilution: No common stock was issued in the last six consecutive quarters. All third-party vendors who received stock issued from the treasury are subject to a mandatory leak out of securities which are 15% of the average daily trading volume, computed over the last 30 trading days. Three-Month Gross Revenue Increase : Gross Revenue increased $9,506 or 12.27% to $77,461 for the three months ended September 30, 2022, as compared to $67,955 for the three months ended September 30, 2021. Three Month Net Revenue Increase : Net Revenue, increased from $43,067 to $47,044 an increase of 8.45% or $3,977 on September 30, 2022, as compared to the three months ended September 30, 2021.  Profit Margin : On September 30, 2022, the company demonstrated a 39.26% profit margin pricing structure in its business model up from 38.58% three months ended September 30, 2021 Shareholder Equity Increase : An increase of $72,361 or 4.65% which is $1,554,250 on September 30, 2022, from $1,481,889 on September 30, 2021. Cash and Cash Equivalents Increase: Increased to $179,661 on September 30, 2022, or 11.9%, an increase from $158,195 for the same period ended September 30, 2021. About Novus Novus Acquisition & Development Corp. ( NDEV ), through its subsidiary WCIG Insurance, Services, Inc. provides health insurance and related insurance solutions within the wellness and medical marijuana industries in states where legal programs exist. Novus has developed its infrastructure within many lines of the insurance business such as health, life, and fixed annuities. As a carrier Novus relies on two key indicators to measure value and performance. The Benefit Monetization Ratio is defined as the total number of policies, monetized annually, which is offset by the operating cost ratio which is a Balance Sheet line item computed as Net Asset Value. Novus’ medical cannabis benefits package will work as outside developers and will not cultivate, handle, transport grow, extract, dispense, put up for sale, put on the market, vend, deliver, supply, circulate, or trade cannabis or any substances that violate the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. The statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure, or prevent disease. All information provided on these press releases, or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional. All cannabis transaction is solely between the state-licensed dispensary and the registered patient. The state laws conflict with the federal Controlled Substances Act. The current administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state-designated laws, allowing the use and distribution of medical marijuana. Changes in consolidation may affect the provider network. However, there is no guarantee that the current administration, nor any future administration, will not change this policy and decide to enforce the federal laws strongly. Any such change in the federal government's enforcement of current federal laws could cause significant financial changes. While we do not intend to harvest, distribute, or sell cannabis or cannabis-related products, we may be harmed by a change in enforcement by federal or state governments. Forward-Looking Statements This release includes forward-looking statements, which are based on certain assumptions and reflect management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. Novus disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Additionally, this press release that is not statements of historical fact may be considered to be forward-looking statements. Written words, such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future. Information from this press release came from https://www.youtube.com/watch?v=ptVvbbIV8-U Investor Contact Information 855-228-7355 Email: [email protected]

View stock analysis, news, and events for Novus Acquisition & Development Corp.